Intellia Therapeutics Inc. (NTLA) Slipped -6.16% or -1.12 To Price $17.14 On Wednesday


Intellia Therapeutics Inc. (NTLA) slipped -6.16% or -1.12 to $17.14. It is approximately 158500 shares traded, which is 20.69% compare to the average total volume 766130. The market cap of NTLA is $743.99 million. The year to date change is -21.27%. The 52 week price range is from $16.33 to $35.99. Price of NTLA have changed -5.83% during last week. It have changed -18.12% over last month, -34.01% over last 3 months, -18.59% over last 6 months and -8.29% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NTLA is 24.24. It is 41.42% above current price. The 200-day Moving Averages for NTLA is 25.64. It is 49.59% above current price. The 52-week High is 35.99. It is 109.98% from the current price. The 52-week Low is 16.33. It is -4.73% from current price.

There are some statistics of NTLA. It is has market cap $743.99 million. The share outstanding is 43.42 million. The average volume is 766130. The percent of top 15 Institution holding is 46.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NTLA is -41.27%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NTLA is -31.78%.


Tags:

Share this post